Skip to main content
. 2022 Oct 12;10:1026248. doi: 10.3389/fbioe.2022.1026248

FIGURE 7.

FIGURE 7

The use of Lmo@RBC to improve cancer immunotherapy. (A) Schematic illustration of the preparation and application of Lmo@RBC. (B) Schematic depiction of Lmo@RBC used for therapy in CT26 distant tumor-bearing mice. Primary tumor volume curve (C), images of solid tumor (D), and body weight (E) of mice intravenously administered with PBS, Lmo, BMS-1, Lmo@RBC, Lmo + BMS-1, or Lmo@RBC + BMS-1. Reproduced with permission from Liu et al. (2022). Copyright 2022, American Chemical Society.